Drug delivery strategies in the therapy of inflammatory bowel disease
Lautenschlaeger C, Schmidt C, Fischer D, Stallmach A (2014)
Publication Type: Journal article, Review article
Publication year: 2014
Journal
Book Volume: 71
Pages Range: 58-76
DOI: 10.1016/j.addr.2013.10.001
Abstract
Inflammatory bowel disease (IBD) is a frequently occurring disease in young people, which is characterized by a chronic inflammation of the gastrointestinal tract. The therapy of IBD is dominated by the administration of anti-inflammatory and immunosuppressive drugs, which suppress the intestinal inflammatory burden and improve the disease-related symptoms. Established treatment strategies are characterized by a limited therapeutical efficacy and the occurrence of adverse drug reactions. Thus, the development of novel disease-targeted drug delivery strategies is intended for a more effective therapy and demonstrates the potential to address unmet medical needs. This review gives an overview about the established as well as future-oriented drug targeting strategies, including intestine targeting by conventional drug delivery systems (DDS), disease targeted drug delivery by synthetic DDS and disease targeted drug delivery by biological DDS. Furthermore, this review analyses the targeting mechanisms of the respective DDS and discusses the possible field of utilization in IBD. © 2014 Elsevier B.V.
Authors with CRIS profile
Involved external institutions
Germany (DE)How to cite
APA:
Lautenschlaeger, C., Schmidt, C., Fischer, D., & Stallmach, A. (2014). Drug delivery strategies in the therapy of inflammatory bowel disease. Advanced Drug Delivery Reviews, 71, 58-76. https://doi.org/10.1016/j.addr.2013.10.001
MLA:
Lautenschlaeger, Christian, et al. "Drug delivery strategies in the therapy of inflammatory bowel disease." Advanced Drug Delivery Reviews 71 (2014): 58-76.
BibTeX: Download